Histopathological evaluation of the effectiveness of oral Eppikajutsuto treatment for lymphatic malformation
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Oct 2020 · 1 min read
In brief
In brief
Experimental study demonstrates that oral Eppikajutsuto (TJ-28), a Japanese herbal medicine, significantly reduces lymphatic vessel dilation in a mouse model of lymphatic malformation. This is the first histopathological evidence supporting TJ-28 as an alternative therapy to standard sclerotherapy and surgical excision for LMs.
Written by the GCMD Library team from the article.
Abstract
Background
Lymphatic malformation (LM) is a congenital disease caused by lymphatic vessel malformation. Although standard therapies for LMs are sclerotherapy and/or surgical excision, a new therapy using Japanese herbal medicine Eppikajutsuto (TJ-28) has been recently reported as clinically effective. We aimed to experimentally confirm the therapeutic effectiveness of TJ-28 for LMs.
Methods
LM lesions were generated in the mesentery and peritoneum of mice by intraperitoneal injection of Freund's incomplete adjuvant. Mice with LMs were treated by gavage or dietary administration of TJ-28 for 2 months. Formalin-fixed paraffin-embedded tissue sections of mesentery and peritoneum tissues were histologically and immunohistochemically examined by focusing on lymph nodes and perinodal lymph vessels.
Results
Multiple Freund's incomplete adjuvant-associated foreign-body granulomas were formed in the mesentery and peritoneum, resulting in congestion of lymph fluid and dilatation of lymph vessels. The numbers and sizes of lymph nodes were not significantly different between TJ-28-treated and control groups. However, the luminal areas of lymphatic vessels were reduced significantly in the TJ-28 treatment group by both gavage and dietary administrations.
Conclusion
TJ-28 conspicuously reduced congestion of lymph fluid. This is the first histopathological evaluation of LM model mice to study the effectiveness of oral TJ-28 treatment.